Researchers from the National Institute of Health’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) and collaborating institutions have developed a novel protein expression-based stemness index (PROTsi) to evaluate oncogenic dedifferentiation in cancer. Their work, published in Cell Genomics, aims to quantify stem-like features in cancer which are closely linked to aggressive tumor behavior, resistance to therapies, and poor patient outcomes.…